quarter 0.193187727525584
sales 0.176624905073968
year 0.163723301960171
growth 0.154989981865843
strategy 0.154488769827224
phase 0.150881072826178
strong 0.132320565956653
statements 0.124310002722646
plavix 0.114597754455166
pearls 0.114597754455166
squibb 0.114597754455166
elicker 0.114597754455166
hepatitis 0.114597754455166
abilify 0.114597754455166
pipeline 0.114566653156875
earnings 0.113897440383978
basis 0.11153495733651
jim 0.109805491385677
exchange 0.106659269714317
foreign 0.106313264731221
guidance 0.104761719308773
data 0.098561761826499
results 0.0978897958249817
good 0.0978897958249817
excluding 0.0950159720898724
call 0.0932855597978382
share 0.09308930410544
gaap 0.0905286436957065
iii 0.0905286436957065
turn 0.089972200012969
execute 0.0888426041830609
morning 0.088350906485451
continuing 0.0854368262338792
europe 0.0828733351484305
productivity 0.0813213360396062
fourth 0.0809498022741309
globally 0.0794365042238531
huet 0.0763985029701109
virology 0.0763985029701109
bipolar 0.0763985029701109
dapagliflozin 0.0763985029701109
alzheimers 0.0763985029701109
cornelius 0.0763985029701109
onglyza 0.0763985029701109
sustiva 0.0763985029701109
apixaban 0.0763985029701109
baraclude 0.0763985029701109
diabetes 0.0763985029701109
trends 0.0762252564479019
opportunities 0.0751826807171644
continue 0.074970178681936
joining 0.07294801858005
biopharma 0.0720728458742421
prescription 0.0720728458742421
estimates 0.070737257481267
officer 0.0701980952694616
solid 0.0697367708040987
achieve 0.0697367708040987
promising 0.0690037433222086
disease 0.0690037433222086
adapt 0.0690037433222086
development 0.0680838158526259
areas 0.0658775569970527
business 0.0646357995568271
form 0.0618558791081966
operations 0.061845202251989
improvements 0.0616089836743064
string 0.060352429130471
medical 0.060352429130471
shared 0.060352429130471
range 0.0596451180094137
today 0.0589023683994038
financials 0.0582115972798369
transformation 0.0572833265784376
initiative 0.0572833265784376
indication 0.0564294003108086
john 0.0561778235772982
diluted 0.0556387880751395
goals 0.0549027456928385
execution 0.0549027456928385
turning 0.0549027456928385
supported 0.0549027456928385
chief 0.0538035514260696
cost 0.0536813539517477
ii 0.0523808596543867
external 0.051833643140805
company 0.0517643681323142
full 0.050912601868963
position 0.0506162494253822
quickly 0.0503426092005769
work 0.0503252855076908
confident 0.0494530622552059
quick 0.0490346406629063
prepared 0.0482440284272373
challenges 0.0464911805360658
due 0.0460493409053461
companys 0.0458634475416381
relations 0.0455629098346665
major 0.0451899357745396
success 0.0441754532427255
announced 0.0430400210403518
start 0.0418470405934642
coming 0.0406604429106157
base 0.0404749011370655
important 0.0402925311735795
addition 0.039259300129405
time 0.0391612242311365
investor 0.0389359910518399
reports 0.0387779380414307
financial 0.0387070230041251
product 0.0383173607738968
sprycel 0.0381992514850555
acute 0.0381992514850555
newer 0.0381992514850555
interferon 0.0381992514850555
cardiology 0.0381992514850555
rebasing 0.0381992514850555
apotex 0.0381992514850555
depressive 0.0381992514850555
tumors 0.0381992514850555
reallocation 0.0381992514850555
kidney 0.0381992514850555
dtc 0.0381992514850555
coronary 0.0381992514850555
transplant 0.0381992514850555
antipsychotic 0.0381992514850555
sigal 0.0381992514850555
zymogenetics 0.0381992514850555
budgeted 0.0381992514850555
biologic 0.0381992514850555
amplify 0.0381992514850555
hematologic 0.0381992514850555
andreotti 0.0381992514850555
lamberto 0.0381992514850555
pad 0.0381992514850555
malignancies 0.0381992514850555
convatec 0.0381992514850555
neuroscience 0.0381992514850555
disorder 0.0381992514850555
inhibitor 0.0381992514850555
adnexisin 0.0381992514850555
unmet 0.0381992514850555
leaner 0.0381992514850555
exelixis 0.0381992514850555
reyataz 0.0381992514850555
syndrome 0.0381992514850555
atripla 0.0381992514850555
advancing 0.0381992514850555
compared 0.0378758474343293
rates 0.0377326455114348
portfolio 0.0374518823848655
review 0.0370441238450005
put 0.0370441238450005
early 0.0369115956429289
impact 0.0369115956429289
annual 0.0363973571558316
therapeutic 0.036036422937121
timeframe 0.036036422937121
resetting 0.036036422937121
rigor 0.036036422937121
monetization 0.036036422937121
patient 0.036036422937121
agile 0.036036422937121
color 0.036036422937121
prevention 0.036036422937121
underscore 0.036036422937121
compounded 0.036036422937121
scientific 0.036036422937121
cancer 0.036036422937121
medicines 0.036036422937121
monies 0.036036422937121
disclaim 0.036036422937121
promises 0.036036422937121
elect 0.036036422937121
additional 0.0356696854158372
plans 0.0350990476347308
operating 0.0349884934529359
strides 0.0345018716611043
capping 0.0345018716611043
gentlemen 0.0345018716611043
advancement 0.0345018716611043
productive 0.0345018716611043
touch 0.0345018716611043
mechanism 0.0345018716611043
decisive 0.0345018716611043
recent 0.0342451213671018
rate 0.034041907926313
billion 0.0339935446335915
result 0.0339417345793087
performance 0.0338424930908954
listening 0.0333115812183048
cv 0.0333115812183048
executing 0.0333115812183048
presenting 0.0333115812183048
patients 0.0333115812183048
elliott 0.0333115812183048
rejection 0.0333115812183048
measured 0.0333115812183048
ladies 0.0333115812183048
based 0.0328977715256772
total 0.0324550364989544
pharma 0.0323390431131699
underway 0.0323390431131699
clinical 0.0323390431131699
compound 0.0323390431131699
treatment 0.0323390431131699
fda 0.0323390431131699
internally 0.0323390431131699
witnessed 0.0315167738615209
identifying 0.0315167738615209
alliances 0.0315167738615209
mr 0.0313831783935284
future 0.0309979963731685
negatively 0.0308044918371532
instructions 0.0308044918371532
stages 0.0308044918371532
starts 0.0308044918371532
poised 0.0308044918371532
make 0.0305534160842994
periodic 0.0301762145652355
dramatically 0.0301762145652355
remarks 0.0301762145652355
equivalents 0.0301762145652355
busy 0.0301762145652355
evaluate 0.0301762145652355
proud 0.0296142013943536
made 0.0291288520355639
presented 0.0291057986399184
relied 0.0291057986399184
submit 0.0291057986399184
goal 0.0291057986399184
rich 0.0291057986399184
summary 0.0291057986399184
tracking 0.0291057986399184
harbor 0.0291057986399184
promise 0.0291057986399184
actively 0.0286416632892188
reaching 0.0286416632892188
constitute 0.0286416632892188
cash 0.0282164687281248
meetings 0.0282147001554043
encouraging 0.0282147001554043
plants 0.0278193940375698
campaign 0.0278193940375698
advance 0.0278193940375698
expanding 0.0274513728464192
todays 0.0274513728464192
reflects 0.0274513728464192
preparing 0.0274513728464192
stage 0.0271071120132021
discussed 0.0271071120132021
potentially 0.0271071120132021
specifically 0.0271071120132021
wider 0.0271071120132021
decreased 0.0267837286686176
volumes 0.0267837286686176
developed 0.0267837286686176
healthy 0.0267837286686176
commitments 0.0264788347412844
sec 0.0264788347412844
true 0.0264788347412844
affecting 0.0264788347412844
years 0.0262035950300307
driven 0.0261904298271934
represent 0.0261904298271934
inventory 0.0261904298271934
usual 0.0261904298271934
obligation 0.0261904298271934
helping 0.0261904298271934
speed 0.0261904298271934
including 0.0261074828207577
seek 0.0259168215704025
purposes 0.0259168215704025
culture 0.0259168215704025
submitted 0.0259168215704025
reform 0.0256565654896354
documents 0.0256565654896354
prospects 0.0256565654896354
improving 0.0256565654896354
discuss 0.0254084188159673
reach 0.0254084188159673
grew 0.0251713046002885
uncertainties 0.0251713046002885
positioned 0.0249442834652677
met 0.0249442834652677
started 0.0249442834652677
subsequent 0.0249442834652677
approach 0.0249442834652677
keeping 0.0249442834652677
impacted 0.0247265311276029
delivering 0.0247265311276029
minimum 0.0247265311276029
franchise 0.0247265311276029
excellent 0.0245173203314532
manufacturing 0.0245173203314532
initiatives 0.0245173203314532
representing 0.0245173203314532
comments 0.0245173203314532
safe 0.0245173203314532
scheduled 0.0245173203314532
programs 0.02431600619335
pleased 0.0241220142136186
james 0.0241220142136186
rapid 0.0241220142136186
expansion 0.0241220142136186
launched 0.0241220142136186
show 0.0241220142136186
july 0.0237539930224681
differ 0.0237539930224681
deliver 0.0237539930224681
litigation 0.023579085827089
japan 0.0234097321892509
questions 0.0234097321892509
margins 0.0234097321892509
struggling 0.0232455902680329
vice 0.0232455902680329
leader 0.0230863488446665
negative 0.0230863488446665
materially 0.0229317237708191
grow 0.0227814549173333
website 0.0227814549173333
expenses 0.0226353035411158
resources 0.0226353035411158
reduction 0.0224930500032422
hard 0.0224930500032422
positive 0.0224930500032422
factors 0.0222194417464514
create 0.0222194417464514
providing 0.0220877266213627
actual 0.0219591856656842
represents 0.0219591856656842
outlook 0.0219591856656842
project 0.0219591856656842
acquisitions 0.0218336694855539
successful 0.0218336694855539
health 0.0217110389920162
operator 0.0217110389920162
point 0.0215911644745337
legal 0.0214739247763373
conference 0.0214739247763373
act 0.0213592065584698
lot 0.0212469036413165
ahead 0.0211369164140352
research 0.0210291513036518
managed 0.0210291513036518
revenues 0.0210291513036518
approval 0.0210291513036518
building 0.0209235202967321
face 0.020819940507502
short 0.0206186263693989
network 0.0205207485492166
date 0.0205207485492166
forward 0.0204246343896675
decision 0.0204246343896675
focus 0.0201462655867898
change 0.020056613198517
provisions 0.0199684427359479
included 0.0197963571177498
continues 0.0197123523652998
release 0.0197123523652998
ended 0.0196296500647025
continued 0.0196296500647025
president 0.0195482104440818
added 0.0195482104440818
approximately 0.0193889690207154
update 0.0193110962284029
great 0.0193110962284029
received 0.0192343439468679
fall 0.0190840750933821
day 0.0190840750933821
remain 0.0189379237171647
ago 0.0187259411924328
working 0.0185220619225002
leading 0.0184557978214645
strategic 0.0184557978214645
significant 0.0183903467974116
potential 0.0183903467974116
environment 0.0183256891386516
details 0.0182618058417331
team 0.0181362896616028
half 0.0179533851760656
taking 0.0178348427079186
term 0.0177765449523862
private 0.0175495238173654
acquisition 0.0174942467264679
products 0.0174395365900841
earlier 0.0174395365900841
plan 0.0173853818961474
key 0.0172786945090804
international 0.0171225606835509
world 0.0170715153989335
high 0.0167750951692303
past 0.0166328416313567
shareholders 0.0166328416313567
net 0.0165862545095866
report 0.0164942834116332
increase 0.0164942834116332
profit 0.0163149659708303
industry 0.0162710629119968
period 0.0162710629119968
fund 0.0160149725413487
chairman 0.0160149725413487
december 0.0159734611136684
part 0.0155369641229168
end 0.015386695269431
week 0.0150285613684816
assets 0.0149940357363872
price 0.0149940357363872
securities 0.0149256477286794
current 0.0148246820985491
corporate 0.0147584179975133
markets 0.0141668524433623
months 0.0141374628839675
companies 0.0137968669025168
management 0.0135026765306609
executive 0.0133741355749824
global 0.0129354618074056
america 0.0120732358780177
market 0.0104547575989448
bank 0.00684628302529526
